Quarterly Results • Search Archive

Lyka Labs Limited
Results, Financials & Updates

Follow Lyka Labs Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

2 published deep dives 2 quarters 1 sector

Company Overview

Lyka Labs Limited: latest results and financials

Latest covered quarterQ2 FY27NSE: LYKALABS
Revenue from operations₹44.20 CrReported in the latest covered quarter
Profit after tax₹1.27 CrReported in the latest covered quarter
EBITDA margin9.37%Latest available reported margin
About the business in Nivata's latest coverage

Lyka Labs Limited operates in the pharmaceuticals sector, focusing on the development, manufacture, and marketing of a wide range of pharmaceutical formulations. The company manages its operations through its registered and corporate footprints primarily centered in Mumbai and Ankleshwar. The primary revenue engine is derived from pharmaceutical operations involving active pharmaceutical ingredients and finished dosage formulations, catering to diverse medical needs. The business model integrates in-house manufacturing capabilities with a structured supply chain spanning domestic and international markets.

Quarter History

Lyka Labs reported trend

Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.

QuarterRevenue / incomePATMargin
Q2 FY27Consolidated₹44.20 Cr₹1.27 Cr9.37%Open ↗
Q1 FY27Consolidated₹42.31 Cr₹2.05 Cr—Open ↗
← All quarterly results

Quarter history

Lyka Labs Limited Results & Financials

Latest Nivata coverage: Q2 FY27 · revenue ₹44.20 Cr · PAT ₹1.27 Cr.